Susanne Kreutz

Global Head, Mergers and Acquisitions | Business Development & Licensing Oncology (ad interim)

Susanne Kreutz

Global Head, Mergers and Acquisitions | Business Development & Licensing Oncology (ad interim)


Novartis International AG, Basel (CH)

Susanne Kreutz is the Global Head of Business Development & Licensing for Oncology at Novartis Pharma AG since October 2019 and is a member of the Novartis Oncology Leadership Team.

Susanne Kreutz is the Global Head of M&A at Novartis International AG since January 2021 and is a member of the Novartis Finance Leadership Team.

Susanne joined Novartis in October 2019 as the Global Head of Business Development & Licensing for Oncology. Before joining Novartis, Susanne served as the Vice President M&A Pharma at Bayer AG. She has a deep and broad experience in M&A and BD&L, having held various global and regional leadership positions across different therapeutic areas for early and late stage partnering at Bayer. As Director & Head of US Pharma BD&L at Bayer, she was responsible for building and leading the new BD&L function across all pharma business units. She also supported a global product (Xofigo) launch during her time as the Deputy Director Global Strategic Marketing for Oncology.

Susanne is a pharmacist by training and holds a PhD in Neuroscience from the University of Frankfurt.